ISSN: 0198-8859

Journal Home

Journal Guideline

Human Immunology Q2 Unclaimed

Elsevier Inc. United States

Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

Human Immunology is a journal indexed in SJR in Medicine (miscellaneous) and Immunology with an H index of 105. It has an SJR impact factor of 0,895 and it has a best quartile of Q2. It is published in English. It has an SJR impact factor of 0,895.

Human Immunology focuses its scope in these topics and keywords: human, cell, alleles, antigen, arthritis, class, ctl, dr, functions, generation, ...

Type: Journal

Type of Copyright:

Languages: English

Open Access Policy:

Type of publications:

Publication frecuency: -

Categories: Immunology (Q2) Immunology and Allergy (Q2) Immunology and Allergy (Q2) Medicine (miscellaneous) (Q2)

Price

- €

Inmediate OA

NPD

Embargoed OA

- €

Non OA

Metrics

0,895

SJR Impact factor

105

H Index

128

Total Docs (Last Year)

293

Total Docs (3 years)

7979

Total Refs

984

Total Cites (3 years)

282

Citable Docs (3 years)

2.29

Cites/Doc (2 years)

62.34

Ref/Doc

Comments

No comments ... Be the first to comment!

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID *

* The email or ORCID field is only to validate the authenticity of the comment, the identity will not be public. .

Other journals with similar parameters

Clinical and Translational Oncology Q2
Neuro-Oncology Practice Q2
Revista de Saude Publica Q2
Human Vaccines and Immunotherapeutics Q2
British Journal of Nutrition Q2

Compare this journals

Aims and Scope

Best articles by citations

Loss of LMP and TAP expression in human melanoma cells

Human autoreactive (Th0) CD4+ T-cell clones with cytolytic activity recognizing autologous activated T cells as the target

Statistical analysis of the matching of cord blood specimen and its impact on the definition of allocation rules

Immune responses in TAP deficient patients

Fast forward at the protein but not at the DNA level of the PERB11 gene family: Implication for rapid diversification to diverse functions

DRA promoter polymorphisms in australian multiple sclerosis patients

TAP-polymorphisms in juvenile onset psoriasis and psoriatic arthritis

There are multiple regulators of expression throughout the MHC

Interaction between HLA-DR and HLA-DP, and Between HLA and interleukin 1a in juvenile rheumatoid arthritis indicates heterogeneity of pathogenic mechanisms of the disease

An association in non-insulin-dependent diabetes mellitus subjects between susceptibility to retinopathy and tumor necrosis factor polymorphism

Subtypes of B44 in six different populations

Vitiligo and HLA-23, A11, B21 and Cw4 in southern iranian patients

SHOW MORE ARTICLES

Loss of TAP1 and LMP2 gene expression in HLA class I-deficient tumor cell lines

Sequencing based typing for HLA DQA

Characterization of a new HLA-B allele (B*3702) generated by an intronic recombination event

Molecular analysis of HLA-B antigens from the warao Indians of venezuela: Novel and conserved alleles and the nature of HLA-B evolution in South America

Subtyping of DR11 positive patients with scleroderma

Decreased frequency of HLADRB1*13 alleles in French women with HPV positive carcinoma of the cervix

Relationship between TH1 and TH2 type cytokines and HLA-linked genetic control of hepatitis B vaccine response

Significant deviation of HLA-C allelic frequencies in Schizophrenic patients defined by sequence based typing (automated DNA sequencer A.L.F.)

Fine-specificity analysis of HLA-A*02 restricted cytotoxic T lymphocytes specific for peptides from tumor associated antigens Mage-3 and Melan-A/MART-1

Frequent loss of heterozygosity on chromosome 6p in uveal melanoma

Age-related association of MHC class I chain-related gene A (MICA) with type 1 (insulin-dependent) diabetes mellitus

Significant HLA-A*02 allelic variation revealed in chinese and caucasian populations